337 related articles for article (PubMed ID: 31479514)
1. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.
Shi J; Li Y; Jia R; Fan X
Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenograft models for the study of benign human neoplasms.
de Souza JC; Miguita L; Gomez RS; Gomes CC
Exp Mol Pathol; 2021 Jun; 120():104630. PubMed ID: 33744281
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived xenograft models: an emerging platform for translational cancer research.
Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A
Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190
[TBL] [Abstract][Full Text] [Related]
4. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
Cells; 2019 May; 8(5):. PubMed ID: 31126020
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
Sun S; Zhang Z
Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
[TBL] [Abstract][Full Text] [Related]
7. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents.
Li X; Li M
Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178
[TBL] [Abstract][Full Text] [Related]
8. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP
Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081
[TBL] [Abstract][Full Text] [Related]
9. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
[TBL] [Abstract][Full Text] [Related]
10. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
[TBL] [Abstract][Full Text] [Related]
11. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
[TBL] [Abstract][Full Text] [Related]
12. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenograft models for personalized medicine in colorectal cancer.
Xie J; Lin Y
Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151
[TBL] [Abstract][Full Text] [Related]
14. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
15. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
Kawaguchi T; Foster BA; Young J; Takabe K
J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
[TBL] [Abstract][Full Text] [Related]
16. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors.
Koga Y; Ochiai A
Cells; 2019 May; 8(5):. PubMed ID: 31064068
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
[TBL] [Abstract][Full Text] [Related]
19. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells.
Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J
J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Bladder Cancer Xenografts.
Bernardo C; Santos LL
Methods Mol Biol; 2018; 1655():169-175. PubMed ID: 28889386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
